Brevan Howard Capital Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-14,297
Closed -$75.9K – 2011
2025
Q1
$75.9K Buy
+14,297
New +$97.7K ﹤0.01% 1070
2024
Q4
– Sell
-16,784
Closed -$132K – 1421
2024
Q3
$132K Sell
16,784
-657
-4% -$5.91K ﹤0.01% 1052
2024
Q2
$180K Sell
17,441
-10,057
-37% -$109K ﹤0.01% 913
2024
Q1
$344K Buy
+27,498
New +$356K ﹤0.01% 602

Other funds holding TBI

Brevan Howard Capital Management's TBI Position: Q2 2025 in Review

Brevan Howard Capital Management sold out of Trueblue (TBI) in Q2 2025, closing a stake of 14,297 shares — an estimated $75.9K sold.

Brevan Howard Capital Management first reported a position in TBI in Q1 2024 and held it in 4 quarters. The position peaked at $344K in Q1 2024. 111 funds tracked by Wall St. Rank hold TBI as of Q2 2025.

  • Brevan Howard Capital Management reported no remaining Trueblue position as of Q2 2025 after selling out during the quarter.
  • Brevan Howard Capital Management sold 14,297 Trueblue shares in Q2 2025, an estimated $75.9K.
  • Brevan Howard Capital Management first reported a position in Trueblue in Q1 2024 and held it in 4 quarters.
  • Brevan Howard Capital Management's Trueblue position peaked at $344K in Q1 2024.
  • 111 funds tracked by Wall St. Rank held Trueblue as of Q2 2025.

Based on Brevan Howard Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.